## GTLB: GitLab Inc. - XLK: Technology

### Executive Summary

No thesis match: MRS_20 -14.2% below STRENGTH zone (4.0-10.0%); PEG 1.43 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-4.3% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($33.05)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 1
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. GitLab Q3 2025 Results: Revenue Surges 24.6%, Profit Tops Forecasts - News and Statistics**
- Source: IndexBox | 20251203T040247 | Bullish | Relevance: 100%
- GitLab (NASDAQ:GTLB) reported Q3 2025 financial results exceeding Wall Street expectations, with revenue surging 24.6% to $244.4 million and non-GAAP profit per share beating estimates by 24%. The company also raised its full-year adjusted EPS guidance to $0.96 at the midpoint. GitLab, a DevSecOps platform provider, has shown strong growth with a 46.9% compounded annual growth rate over five years, and analysts anticipate 18.9% revenue growth in the next 12 months.

### Analyst Activity

**Target Signal:** BEARISH (Raises: 1, Lowers: 10)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-03 | Macquarie | $40 | $70 | -43% |
| 2025-12-03 | BTIG | $52 | $57 | -9% |
| 2025-12-03 | Barclays | $42 | $44 | -5% |
| 2025-12-03 | Goldman Sachs | $42 | $48 | -12% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-03 | Macquarie | down | Neutral |
| 2025-12-03 | BTIG | main | Buy |
| 2025-12-03 | Barclays | main | Equal-Weight |
| 2025-12-03 | Goldman Sachs | main | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.00M) |
| Sells | 14 ($3.88M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 41.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 10 / 0 |

**Top Holders:**
- Vanguard Group Inc: 10.2% (+9.2%)
- Blackrock Inc.: 5.5% (+1.6%)
- Eminence Capital, LP: 4.8% (+15.9%)
- HMI Capital Manageme: 4.3% (+10.4%)
- Atreides Management,: 3.6% (+38.9%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-4.3% 5d) with bearish MACD, trend may be turning.
2. Insider selling cluster: $3.9M in recent transactions.
3. Long-term trend broken: trading 19.7% below SMA200.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.43 suggests fair value with growth premium. Forward P/E 36.5x stretched relative to 16% growth. Balance sheet: strong liquidity (2.7x). Analyst sentiment negative (10 target cuts vs 1 raises). Insider selling cluster ($3.9M in 90 days), potential headwind. Institutional flow bullish (10 buying vs 0 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $6.4B |
| Beta | 0.75 |
| 52W Range | $35.81 - $74.18 |
| Short Interest | 7.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.43 |
| Forward P/E | 36.5 |
| Current P/E | 42.2 |
| YoY Growth | 15.8% |
| EPS Direction | RISING |

### Technicals

MRS_20 deteriorating from -9.9% to -14.2% (-4.3% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 18.2pp (needs >4.0% for momentum thesis). AM_20 at -12.6% indicates price below own 20MA trend. Underperforming sector by 13.8pp, stock-specific weakness. Below SMA200 (0.80x), long-term trend not supportive. Elevated volume (3.2x 20MA), institutional activity likely. OFD pattern: -SLH (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -14.20% (CS: 1) | Weak |
| RSI_14 | 32.6 | Neutral |
| MACD Histogram | -0.30 | Bearish |
| vs SMA20 | 0.874x | Below |
| vs SMA50 | 0.832x | Below |
| vs SMA200 | 0.803x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $37.83
- **Stop Loss:** $33.05 (12.6% risk)
- **Target:** $42.61 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 198
- **Position Value:** $7,490.34
- **Portfolio %:** 7.49%
- **Risk Dollars:** $950.00
- **Risk Per Trade:** 0.95%
- **Modifiers:** L1 95% | L2 100% | Combined 0.95x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderately constructive conditions. Fed dovish pivot expectations from weak jobs data and declining VIX suggest improving risk appetite, though narrow breadth at 51% indicates selective participation. Focus on quality sectors benefiting from rate cut expectations.*

### Earnings

**Next:** 2026-03-02 (Est: $0.23)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $0.20 | $0.25 | +24.0% |
| 2025Q3 | $0.16 | $0.24 | +46.5% |
| 2025Q2 | $0.15 | $0.17 | +12.0% |
| 2025Q1 | $0.23 | $0.33 | +44.6% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*